Open AccessCombination of convalescent plasma therapy and repurposed drugs to treat severe COVID‐19 patient with multimorbidity
Author(s) -
Das Santa Kumar,
Ranabhat Kamal,
Bhattarai Suraj,
Karki Khem Bahadur,
Gyanwali Pradip,
Paneru Hem Raj,
Nepal Bipin,
Dumre Shyam Prakash,
Acharya Subhash Prasad
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3964
Subject(s) - medicine , convalescent plasma , covid-19 , dexamethasone , combination therapy , diabetes mellitus , pharmacotherapy , convalescence , intensive care medicine , pharmacology , virology , disease , endocrinology , outbreak , infectious disease (medical specialty)
Combination of convalescent plasma therapy and repurposed drugs such as dexamethasone and remdesivir could be beneficial for severe COVID‐19 patients with obesity and chronic diseases such as diabetes and hypertension.